A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan

Archives of Internal Medicine

Volumn 165, Issue 13, 2005, Pages 1552-1555

  Wu, Ming Shiang ^a,b   Lee, Wei Jei ^c   Wang, Hsih Hsi ^c   Huang, Shi Pei ^a,b   Lin, Jaw Town ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SERUM; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; TAIWAN;

ADULT; ANTIBODIES, BACTERIAL; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; NEPHELOMETRY AND TURBIDIMETRY; OBESITY, MORBID; OBSERVER VARIATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; STOMACH; TAIWAN;

EID: 23044481475     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.13.1552     Document Type: Article

References (26)

1. MacDonald KG Jr. Overview of the epidemiology of obesity and the early history of procedures to remedy morbid obesity. Arch Surg. 2003;138:357-360.
2. Damcott CM, Sack P, Shuldiner AR. The genetics of obesity. Endocrinol Metab Clin North Am. 2003;32:761-786.
3. Frenck RW Jr, Clemens J. Helicobacter in the developing world. Microbes Infect. 2003;5:705-713.
4. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2004;9(suppl 1):1-6.
5. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol. 2000;54:615-640.
6. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ. 2003;326:737.
7. Murray L, Johnston B, Lane A, et al. Relationship between body mass and gastroesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol. 2003;32:645-650.
8. Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter. Gut. 2003;52:637-640.
9. Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut. 2004;53:187-193.
10. Furuta T, Shirai N, Xiao F, Takashima M, Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002;16:799-806.
11. Tatsuguchi A, Miyake K, Gudis K, et al. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol. 2004;99:2121-2127.
12. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321-333.
13. Scapa E, Boldur II, Gluskin J, Broide E, Bogokowsky H, Eshchar J. Helicobacter pylori before and after gastric reduction for morbid obesity. Obes Surg. 1992;2:371-374.
14. Renshaw AA, Rabaza JR, Gonzalez AM, Verdeja JC. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg. 2001;11:281-283.
15. Ramaswamy A, Lin E, Ramshaw BJ, Smith CD. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg. 2004;139:1094-1096.
16. Kawano S, Kawahara A, Nakai R, Fu HY, Tsuji S, Tsuji M. Helicobacter pylori infection does not affect serum leptin concentration and body mass index. J Gastroenterol. 2001;36:579-580.
17. Kyriazanos ID, Sfiniadakis I, Gizaris V, et al. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol. 2002;34:541-546.
18. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol. 1996;19:149-154.
19. Tsai WL, Yang CY, Lin SF, Fang FM. Impact of obesity on medical problems and quality of life in Taiwan. Am J Epidemiol. 2004;160:557-565.
20. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer in a cohort of 9775 men in Taiwan. Anticancer Res. 1995;15:603-606.
21. Wei JN, Sung FC, Lin CC, Lin RS, Chiang CC, Chuang LM. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA. 2003;290:1345-1350.
22. Lee WJ, Huang MT, Wang W, Lin CM, Chen TC, Lai IR. Effects of obesity surgery on the metabolic syndrome. Arch Surg. 2004;139:1088-1092.
23. EUROGAST Study Group. Epidemiology of and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut. 1993;34:1672-1676.
24. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
25. Candelli M, Rigante D, Marietti G, et al. Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics. 2003;111:800-803.
26. Gokcel A, Gumurdulu Y, Kayaseluck F, et al. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol. 2003;148:423-426.